Welcome to Hunan Xingchen Biotechnology Co., Ltd. website.

core product

Artemisinin,QHS

Artemisinin (QHS) is a sesquiterpene lactone compound extracted from the traditional Chinese herbal medicine Qinghao (Artemisia Annua), characterized by its unique peroxide bridge structure. As a highly effective, fast-acting, and low-toxicity anti-malarial drug, Artemisinin demonstrates significant efficacy against various types of malaria, including cerebral malaria, malignant malaria, and tertian malaria. Due to its excellent pharmacological properties, Artemisinin has become the World Health Organization's recommended first-line treatment for malaria, making a substantial contribution to global malaria prevention and control efforts.

Product Introduction

Artemisinin is a new anti-malarial drug that was isolated by Chinese chemists in 1972 from the traditional Chinese herbal medicine Qinghao (Artemisia Annua, a plant of the Asteraceae family). It is characterized by its high efficiency, rapid action, low toxicity, and resistance to drug tolerance.

 

Until today, malaria remains a major killer that threatens human life. Approximately 400 million people worldwide are infected with malaria every year, and 450,000 people lost their precious lives due to malaria, most of whom are children in underdeveloped areas.

 

The discovery of Artemisinin has brought hope to those suffering from malaria. Compared to similarly effective drugs produced by Western pharmaceutical companies, Artemisinin-based medications not only have mild side effects and high cure rates but are also affordable. As a result, many people in Africa refer to this miraculous drug as the "Oriental Miracle Drug."

 

The discovery of Artemisinin is a revolutionary medical advancement in China, considered one of the greatest medical innovations of the second half of the 20th century. It is a new breakthrough in the history of anti-malarial drug research, following quinoline drugs, and a major scientific research achievement in inheriting and promoting traditional Chinese scientific resources. In 2015, Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her contribution to the discovery of the new anti-malarial drug Artemisinin, which is of great significance to our country.

 

Hunan Xingchen Biotechnology Co., Ltd., relying on the unique climate and geographical advantages of Yongzhou City, has vigorously developed the cultivation and processing of traditional Chinese medicine (QinghaoArtemisia Annua) in Yongzhou City since 2012 with the strong support of various levels of government in Yongzhou City. The company has passed ISO9001 certification and obtained EHS certification from The Global Fund in 2017. In 2023, Hunan Xingchen produced 100 tons of Artemisinin, 20 tons of Artemisia Annua oil, 200 tons of Artemisia Annua wax, and 6,000 tons of Artemisia Annua powder, accounting for about 20% of the total Artemisinin production in China.


The Main Functions of Artemisinin:

1. Antimalarial: Artemisinin is currently one of the most effective antimalarial drugs available, particularly for cerebral malaria and chloroquine-resistant malaria, offering rapid efficacy with low toxicity.

2. Antitumor: Artemisinin can induce apoptosis in various cancer cells and inhibit cancer cell growth.


Product Name: Artemisinin

Appearance: Colorless needles or white crystalline powder

Specification: Artemisinin content is greater than 99%, other specifications comply with the 2020 edition of the Chinese Pharmacopoeia

CAS Number: 63968-64-9

Molecular Formula: C15H22O5

Molecular Weight: 282.33

Certificates: ISO9001/COA

Testing Method: HPLC


Uses: Artemisinin has the following effects:

1.Anti-malarial Effect: The active ingredients in Artemisinin such as dihydroartemisinin and artemether can effectively kill malaria parasites.

2.Anti-tumor Efficacy: It also exhibits anti-tumor properties.


Package:

1kg/bag        


25kg/bucket